Literature DB >> 14510254

Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Philip Carling1, Teresa Fung, Ann Killion, Norma Terrin, Michael Barza.   

Abstract

OBJECTIVE: To evaluate the impact of an interventional multidisciplinary antibiotic management program on expenditures for antibiotics and on the incidence of nosocomial infections caused by Clostridium difficile and antibiotic-resistant pathogens during 7 years.
DESIGN: Prospective study with comparison with preintervention trends.
SETTING: University-affiliated teaching hospital. PATIENTS: All adult inpatients. INTERVENTION: A multidisciplinary antibiotic management program to minimize the inappropriate use of third-generation cephalosporins was implemented in 1991. Its impact was evaluated prospectively. The incidence of nosocomial C. difficile and resistant Enterobacteriaceae infections as well as the rate of vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) were compared with those of National Nosocomial Infections Surveillance System hospitals of similar size.
RESULTS: Following implementation of the program, there was a 22% decrease in the use of parenteral broad-spectrum antibiotics (P < .0001) despite a 15% increase in acuity of patient care during the following 7 years. Concomitantly, there was a significant (P = .002) decrease in nosocomial infections caused by C. difficile and a significant (P = .02) decrease in nosocomial infections caused by resistant Enterobacteriaceae. The program also appeared to have a favorable impact on VRE rates without a sustained impact on MRSA rates.
CONCLUSION: These results suggest that an ongoing multidisciplinary antibiotic management program may have a sustained beneficial impact on both expenditures for antibiotics and the incidence of nosocomial infection by C. difficile and resistant bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510254     DOI: 10.1086/502278

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  84 in total

1.  Clostridium difficile infection in hospitals: a brewing storm.

Authors:  Louis Valiquette; Donald E Low; Jacques Pépin; Allison McGeer
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

2.  Antimicrobial stewardship.

Authors:  Shira Doron; Lisa E Davidson
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

3.  Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study.

Authors:  Lucas Magedanz; Erci Maria Silliprandi; Rodrigo Pires dos Santos
Journal:  Int J Clin Pharm       Date:  2012-03-01

Review 4.  Local formularies.

Authors:  D John M Reynolds; Olubunmi Fajemisin; Sara Wilds
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

5.  Clostridioides difficile infection in US hospitals: a national inpatient sample study.

Authors:  Daryl Ramai; Khoi Paul Dang-Ho; Chris Lewis; Paul J Fields; Andrew Ofosu; Mohamed Barakat; Ali Aamar; Emmanuel Ofori; Jonathan Lai; Gandhi Lanke; Amaninder Dhaliwal; Madhavi Reddy; James Gasperino
Journal:  Int J Colorectal Dis       Date:  2020-06-17       Impact factor: 2.571

Review 6.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 7.  Unnatural selection: reducing antibiotic resistance in neonatal units.

Authors:  D Isaacs
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01       Impact factor: 5.747

8.  Predictors of Clostridium difficile colitis infections in hospitals.

Authors:  R Ricciardi; K Harriman; N N Baxter; L K Hartman; R J Town; B A Virnig
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

9.  Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore.

Authors:  C-L Yeo; D S-G Chan; A Earnest; T-S Wu; S-F Yeoh; R Lim; R Jureen; D Fisher; L-Y Hsu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-04       Impact factor: 3.267

Review 10.  A review of the economics of treating Clostridium difficile infection.

Authors:  Kari A Mergenhagen; Amy L Wojciechowski; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.